Journal
VASCULAR MEDICINE
Volume 21, Issue 2, Pages 146-155Publisher
SAGE PUBLICATIONS LTD
DOI: 10.1177/1358863X15618268
Keywords
Cardiac syndrome X; chest pain syndromes; coronary artery disease; endothelial dysfunction; microvascular angina; NoCAD
Categories
Ask authors/readers for more resources
Up to half of patients with signs and symptoms of stable ischemic heart disease have non-obstructive coronary artery disease (NoCAD). Recent evidence demonstrates that two-thirds of patients with NoCAD have demonstrable coronary endothelial dysfunction represented by microvascular or diffuse epicardial spasm following acetylcholine challenge. Patients with coronary endothelial dysfunction are recognized to have significant health services use and morbidity as well as increased risk of developing flow-limiting coronary artery disease and myocardial events, including death. Currently, there are few centers that test for this etiology owing to lack of knowledge, limited evidence for treatment options and invasive diagnostic strategies. This article reviews the pathophysiology, epidemiology, diagnosis and treatment of coronary endothelial dysfunction as a subgroup of NoCAD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available